Norsworthy, K. J., Ko, C., Lee, J. E., Liu, J., John, C. S., Przepiorka, D., . . . Pazdur, R. (2018). FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33‐Positive Acute Myeloid Leukemia. Oncologist.

Norsworthy, Kelly J., Chia‐Wen Ko, Jee Eun Lee, Jiang Liu, Christy S. John, Donna Przepiorka, Ann T. Farrell, e Richard Pazdur. "FDA Approval Summary: Mylotarg for Treatment of Patients With Relapsed or Refractory CD33‐Positive Acute Myeloid Leukemia." Oncologist 2018.

Norsworthy, Kelly J., et al. "FDA Approval Summary: Mylotarg for Treatment of Patients With Relapsed or Refractory CD33‐Positive Acute Myeloid Leukemia." Oncologist 2018.